nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Acamprosate—Discomfort—Triamcinolone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Acamprosate—Discomfort—Methylprednisolone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Acamprosate—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Acamprosate—Angioedema—Dexamethasone—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Acamprosate—Angioedema—Betamethasone—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Acamprosate—Stomatitis—Methotrexate—ankylosing spondylitis	0.00147	0.00147	CcSEcCtD
Acamprosate—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00147	0.00147	CcSEcCtD
Acamprosate—Immune system disorder—Prednisone—ankylosing spondylitis	0.00147	0.00147	CcSEcCtD
Acamprosate—Malaise—Dexamethasone—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Acamprosate—Malaise—Betamethasone—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Acamprosate—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Acamprosate—Vertigo—Betamethasone—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Acamprosate—Vertigo—Dexamethasone—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Acamprosate—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Acamprosate—Syncope—Dexamethasone—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Acamprosate—Syncope—Betamethasone—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Acamprosate—Infection—Triamcinolone—ankylosing spondylitis	0.00145	0.00145	CcSEcCtD
Acamprosate—Sweating—Methotrexate—ankylosing spondylitis	0.00145	0.00145	CcSEcCtD
Acamprosate—Infection—Methylprednisolone—ankylosing spondylitis	0.00145	0.00145	CcSEcCtD
Acamprosate—Haematuria—Methotrexate—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Acamprosate—Shock—Triamcinolone—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Acamprosate—Insomnia—Prednisolone—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Acamprosate—Alopecia—Prednisone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Acamprosate—Shock—Methylprednisolone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Acamprosate—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Acamprosate—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Acamprosate—Epistaxis—Methotrexate—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Acamprosate—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Acamprosate—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Acamprosate—Mental disorder—Prednisone—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Acamprosate—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Acamprosate—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Acamprosate—Malnutrition—Prednisone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Acamprosate—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Acamprosate—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Acamprosate—Convulsion—Dexamethasone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Acamprosate—Convulsion—Betamethasone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Acamprosate—Hypertension—Betamethasone—ankylosing spondylitis	0.0014	0.0014	CcSEcCtD
Acamprosate—Hypertension—Dexamethasone—ankylosing spondylitis	0.0014	0.0014	CcSEcCtD
Acamprosate—Myalgia—Dexamethasone—ankylosing spondylitis	0.00138	0.00138	CcSEcCtD
Acamprosate—Myalgia—Betamethasone—ankylosing spondylitis	0.00138	0.00138	CcSEcCtD
Acamprosate—Anxiety—Betamethasone—ankylosing spondylitis	0.00138	0.00138	CcSEcCtD
Acamprosate—Anxiety—Dexamethasone—ankylosing spondylitis	0.00138	0.00138	CcSEcCtD
Acamprosate—Discomfort—Betamethasone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Acamprosate—Discomfort—Dexamethasone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Acamprosate—Haemoglobin—Methotrexate—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Acamprosate—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Acamprosate—Pain—Prednisolone—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Acamprosate—Haemorrhage—Methotrexate—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Acamprosate—Hepatitis—Methotrexate—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Acamprosate—Pharyngitis—Methotrexate—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00133	0.00133	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00133	0.00133	CcSEcCtD
Acamprosate—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Acamprosate—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Acamprosate—Insomnia—Triamcinolone—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Acamprosate—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Acamprosate—Infection—Dexamethasone—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Acamprosate—Infection—Betamethasone—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Acamprosate—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Acamprosate—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Acamprosate—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Acamprosate—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Acamprosate—Visual impairment—Methotrexate—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Acamprosate—Anaemia—Prednisone—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Acamprosate—Shock—Betamethasone—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Acamprosate—Shock—Dexamethasone—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Acamprosate—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Acamprosate—Agitation—Prednisone—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Acamprosate—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Acamprosate—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Acamprosate—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Acamprosate—Tachycardia—Betamethasone—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Acamprosate—Angioedema—Prednisone—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Acamprosate—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00128	0.00128	CcSEcCtD
Acamprosate—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00128	0.00128	CcSEcCtD
Acamprosate—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00128	0.00128	CcSEcCtD
Acamprosate—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00128	0.00128	CcSEcCtD
Acamprosate—Malaise—Prednisone—ankylosing spondylitis	0.00127	0.00127	CcSEcCtD
Acamprosate—Vertigo—Prednisone—ankylosing spondylitis	0.00127	0.00127	CcSEcCtD
Acamprosate—Syncope—Prednisone—ankylosing spondylitis	0.00127	0.00127	CcSEcCtD
Acamprosate—Tinnitus—Methotrexate—ankylosing spondylitis	0.00127	0.00127	CcSEcCtD
Acamprosate—Anorexia—Dexamethasone—ankylosing spondylitis	0.00126	0.00126	CcSEcCtD
Acamprosate—Anorexia—Betamethasone—ankylosing spondylitis	0.00126	0.00126	CcSEcCtD
Acamprosate—Urticaria—Prednisolone—ankylosing spondylitis	0.00126	0.00126	CcSEcCtD
Acamprosate—Pain—Triamcinolone—ankylosing spondylitis	0.00125	0.00125	CcSEcCtD
Acamprosate—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Acamprosate—Hypotension—Dexamethasone—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Acamprosate—Hypotension—Betamethasone—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Acamprosate—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00123	0.00123	CcSEcCtD
Acamprosate—Convulsion—Prednisone—ankylosing spondylitis	0.00122	0.00122	CcSEcCtD
Acamprosate—Hypertension—Prednisone—ankylosing spondylitis	0.00122	0.00122	CcSEcCtD
Acamprosate—Chills—Methotrexate—ankylosing spondylitis	0.00122	0.00122	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00121	0.00121	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00121	0.00121	CcSEcCtD
Acamprosate—Myalgia—Prednisone—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Acamprosate—Arthralgia—Prednisone—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Acamprosate—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Acamprosate—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Acamprosate—Anxiety—Prednisone—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Acamprosate—Alopecia—Methotrexate—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Acamprosate—Insomnia—Betamethasone—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Acamprosate—Insomnia—Dexamethasone—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Acamprosate—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Acamprosate—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Acamprosate—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Acamprosate—Discomfort—Prednisone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Acamprosate—Mental disorder—Methotrexate—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Acamprosate—Malnutrition—Methotrexate—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Acamprosate—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Acamprosate—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Acamprosate—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Acamprosate—Urticaria—Triamcinolone—ankylosing spondylitis	0.00116	0.00116	CcSEcCtD
Acamprosate—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00116	0.00116	CcSEcCtD
Acamprosate—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00116	0.00116	CcSEcCtD
Acamprosate—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Acamprosate—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Acamprosate—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Acamprosate—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Acamprosate—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Acamprosate—Infection—Prednisone—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00114	0.00114	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00114	0.00114	CcSEcCtD
Acamprosate—Back pain—Methotrexate—ankylosing spondylitis	0.00114	0.00114	CcSEcCtD
Acamprosate—Shock—Prednisone—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Acamprosate—Pain—Betamethasone—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Acamprosate—Pain—Dexamethasone—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Acamprosate—Tachycardia—Prednisone—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Acamprosate—Skin disorder—Prednisone—ankylosing spondylitis	0.00112	0.00112	CcSEcCtD
Acamprosate—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00112	0.00112	CcSEcCtD
Acamprosate—Anorexia—Prednisone—ankylosing spondylitis	0.0011	0.0011	CcSEcCtD
Acamprosate—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.0011	0.0011	CcSEcCtD
Acamprosate—Anaemia—Methotrexate—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Acamprosate—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Acamprosate—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Acamprosate—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Acamprosate—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Acamprosate—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Acamprosate—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Acamprosate—Malaise—Methotrexate—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Acamprosate—Vertigo—Methotrexate—ankylosing spondylitis	0.00106	0.00106	CcSEcCtD
Acamprosate—Leukopenia—Methotrexate—ankylosing spondylitis	0.00106	0.00106	CcSEcCtD
Acamprosate—Urticaria—Dexamethasone—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Acamprosate—Urticaria—Betamethasone—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Acamprosate—Dizziness—Prednisolone—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Acamprosate—Asthenia—Triamcinolone—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Acamprosate—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Acamprosate—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Acamprosate—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Acamprosate—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Acamprosate—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Acamprosate—Insomnia—Prednisone—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Acamprosate—Paraesthesia—Prednisone—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Acamprosate—Pruritus—Triamcinolone—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Acamprosate—Cough—Methotrexate—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Acamprosate—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Acamprosate—Convulsion—Methotrexate—ankylosing spondylitis	0.00102	0.00102	CcSEcCtD
Acamprosate—Dyspepsia—Prednisone—ankylosing spondylitis	0.00102	0.00102	CcSEcCtD
Acamprosate—Myalgia—Methotrexate—ankylosing spondylitis	0.00101	0.00101	CcSEcCtD
Acamprosate—Chest pain—Methotrexate—ankylosing spondylitis	0.00101	0.00101	CcSEcCtD
Acamprosate—Arthralgia—Methotrexate—ankylosing spondylitis	0.00101	0.00101	CcSEcCtD
Acamprosate—Decreased appetite—Prednisone—ankylosing spondylitis	0.001	0.001	CcSEcCtD
Acamprosate—Rash—Prednisolone—ankylosing spondylitis	0.001	0.001	CcSEcCtD
Acamprosate—Dermatitis—Prednisolone—ankylosing spondylitis	0.001	0.001	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000999	0.000999	CcSEcCtD
Acamprosate—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000997	0.000997	CcSEcCtD
Acamprosate—Headache—Prednisolone—ankylosing spondylitis	0.000994	0.000994	CcSEcCtD
Acamprosate—Discomfort—Methotrexate—ankylosing spondylitis	0.000994	0.000994	CcSEcCtD
Acamprosate—Constipation—Prednisone—ankylosing spondylitis	0.000986	0.000986	CcSEcCtD
Acamprosate—Confusional state—Methotrexate—ankylosing spondylitis	0.000972	0.000972	CcSEcCtD
Acamprosate—Dizziness—Triamcinolone—ankylosing spondylitis	0.000965	0.000965	CcSEcCtD
Acamprosate—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000964	0.000964	CcSEcCtD
Acamprosate—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000963	0.000963	CcSEcCtD
Acamprosate—Infection—Methotrexate—ankylosing spondylitis	0.000958	0.000958	CcSEcCtD
Acamprosate—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00095	0.00095	CcSEcCtD
Acamprosate—Asthenia—Dexamethasone—ankylosing spondylitis	0.00095	0.00095	CcSEcCtD
Acamprosate—Asthenia—Betamethasone—ankylosing spondylitis	0.00095	0.00095	CcSEcCtD
Acamprosate—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000944	0.000944	CcSEcCtD
Acamprosate—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000943	0.000943	CcSEcCtD
Acamprosate—Nausea—Prednisolone—ankylosing spondylitis	0.000943	0.000943	CcSEcCtD
Acamprosate—Pruritus—Betamethasone—ankylosing spondylitis	0.000937	0.000937	CcSEcCtD
Acamprosate—Pruritus—Dexamethasone—ankylosing spondylitis	0.000937	0.000937	CcSEcCtD
Acamprosate—Skin disorder—Methotrexate—ankylosing spondylitis	0.000936	0.000936	CcSEcCtD
Acamprosate—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000932	0.000932	CcSEcCtD
Acamprosate—Vomiting—Triamcinolone—ankylosing spondylitis	0.000928	0.000928	CcSEcCtD
Acamprosate—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000926	0.000926	CcSEcCtD
Acamprosate—Rash—Triamcinolone—ankylosing spondylitis	0.00092	0.00092	CcSEcCtD
Acamprosate—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00092	0.00092	CcSEcCtD
Acamprosate—Anorexia—Methotrexate—ankylosing spondylitis	0.000919	0.000919	CcSEcCtD
Acamprosate—Rash—Methylprednisolone—ankylosing spondylitis	0.000918	0.000918	CcSEcCtD
Acamprosate—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000917	0.000917	CcSEcCtD
Acamprosate—Urticaria—Prednisone—ankylosing spondylitis	0.000916	0.000916	CcSEcCtD
Acamprosate—Headache—Triamcinolone—ankylosing spondylitis	0.000914	0.000914	CcSEcCtD
Acamprosate—Headache—Methylprednisolone—ankylosing spondylitis	0.000912	0.000912	CcSEcCtD
Acamprosate—Abdominal pain—Prednisone—ankylosing spondylitis	0.000912	0.000912	CcSEcCtD
Acamprosate—Body temperature increased—Prednisone—ankylosing spondylitis	0.000912	0.000912	CcSEcCtD
Acamprosate—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000906	0.000906	CcSEcCtD
Acamprosate—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000906	0.000906	CcSEcCtD
Acamprosate—Hypotension—Methotrexate—ankylosing spondylitis	0.000901	0.000901	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000878	0.000878	CcSEcCtD
Acamprosate—Dizziness—Dexamethasone—ankylosing spondylitis	0.000876	0.000876	CcSEcCtD
Acamprosate—Dizziness—Betamethasone—ankylosing spondylitis	0.000876	0.000876	CcSEcCtD
Acamprosate—Insomnia—Methotrexate—ankylosing spondylitis	0.000872	0.000872	CcSEcCtD
Acamprosate—Nausea—Triamcinolone—ankylosing spondylitis	0.000867	0.000867	CcSEcCtD
Acamprosate—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000866	0.000866	CcSEcCtD
Acamprosate—Nausea—Methylprednisolone—ankylosing spondylitis	0.000865	0.000865	CcSEcCtD
Acamprosate—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000859	0.000859	CcSEcCtD
Acamprosate—Somnolence—Methotrexate—ankylosing spondylitis	0.000857	0.000857	CcSEcCtD
Acamprosate—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00085	0.00085	CcSEcCtD
Acamprosate—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000849	0.000849	CcSEcCtD
Acamprosate—Vomiting—Betamethasone—ankylosing spondylitis	0.000842	0.000842	CcSEcCtD
Acamprosate—Vomiting—Dexamethasone—ankylosing spondylitis	0.000842	0.000842	CcSEcCtD
Acamprosate—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000838	0.000838	CcSEcCtD
Acamprosate—Rash—Betamethasone—ankylosing spondylitis	0.000835	0.000835	CcSEcCtD
Acamprosate—Rash—Dexamethasone—ankylosing spondylitis	0.000835	0.000835	CcSEcCtD
Acamprosate—Dermatitis—Betamethasone—ankylosing spondylitis	0.000834	0.000834	CcSEcCtD
Acamprosate—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000834	0.000834	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000832	0.000832	CcSEcCtD
Acamprosate—Headache—Betamethasone—ankylosing spondylitis	0.00083	0.00083	CcSEcCtD
Acamprosate—Headache—Dexamethasone—ankylosing spondylitis	0.00083	0.00083	CcSEcCtD
Acamprosate—Asthenia—Prednisone—ankylosing spondylitis	0.000828	0.000828	CcSEcCtD
Acamprosate—Pain—Methotrexate—ankylosing spondylitis	0.000824	0.000824	CcSEcCtD
Acamprosate—Pruritus—Prednisone—ankylosing spondylitis	0.000816	0.000816	CcSEcCtD
Acamprosate—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000794	0.000794	CcSEcCtD
Acamprosate—Diarrhoea—Prednisone—ankylosing spondylitis	0.000789	0.000789	CcSEcCtD
Acamprosate—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000788	0.000788	CcSEcCtD
Acamprosate—Nausea—Dexamethasone—ankylosing spondylitis	0.000787	0.000787	CcSEcCtD
Acamprosate—Nausea—Betamethasone—ankylosing spondylitis	0.000787	0.000787	CcSEcCtD
Acamprosate—Urticaria—Methotrexate—ankylosing spondylitis	0.000766	0.000766	CcSEcCtD
Acamprosate—Dizziness—Prednisone—ankylosing spondylitis	0.000763	0.000763	CcSEcCtD
Acamprosate—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000762	0.000762	CcSEcCtD
Acamprosate—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000762	0.000762	CcSEcCtD
Acamprosate—Vomiting—Prednisone—ankylosing spondylitis	0.000733	0.000733	CcSEcCtD
Acamprosate—Rash—Prednisone—ankylosing spondylitis	0.000727	0.000727	CcSEcCtD
Acamprosate—Dermatitis—Prednisone—ankylosing spondylitis	0.000727	0.000727	CcSEcCtD
Acamprosate—Headache—Prednisone—ankylosing spondylitis	0.000723	0.000723	CcSEcCtD
Acamprosate—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00071	0.00071	CcSEcCtD
Acamprosate—Asthenia—Methotrexate—ankylosing spondylitis	0.000692	0.000692	CcSEcCtD
Acamprosate—Nausea—Prednisone—ankylosing spondylitis	0.000685	0.000685	CcSEcCtD
Acamprosate—Pruritus—Methotrexate—ankylosing spondylitis	0.000682	0.000682	CcSEcCtD
Acamprosate—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00066	0.00066	CcSEcCtD
Acamprosate—Dizziness—Methotrexate—ankylosing spondylitis	0.000637	0.000637	CcSEcCtD
Acamprosate—Vomiting—Methotrexate—ankylosing spondylitis	0.000613	0.000613	CcSEcCtD
Acamprosate—Rash—Methotrexate—ankylosing spondylitis	0.000608	0.000608	CcSEcCtD
Acamprosate—Dermatitis—Methotrexate—ankylosing spondylitis	0.000607	0.000607	CcSEcCtD
Acamprosate—Headache—Methotrexate—ankylosing spondylitis	0.000604	0.000604	CcSEcCtD
Acamprosate—Nausea—Methotrexate—ankylosing spondylitis	0.000573	0.000573	CcSEcCtD
